摘要
血管内皮抑素是一种广谱的抗血管生成分子靶向物，其通过抑制肿瘤形成过程的病理性血管生成及抑制肿瘤细胞增殖和转移，发挥抗肿瘤作用。近年来随着靶向治疗药物不断进入临床，血管内皮抑素成为肿瘤综合治疗研究的热点之一。
Endostatin is an antitumor molecular targeting angiogenesis of tumor and plays an inhibitory role in tumorigenesis through inhibiting pathological angiogenesis, proliferation and metastasis of tumor. As increasing drugs for targeting therapy aim in clinic, endostatin has become one of hot spots of research on combined treatment of cancer in recent years.
出处
《国际肿瘤学杂志》
CAS
2011年第5期345-348,共4页
Journal of International Oncology
关键词
内皮抑素类
肿瘤
靶向治疗
Endostatins
Neoplasms
Targeted therapy
